Authors:
Gordon, MS
Young, ML
Tallman, MS
Cripe, LD
Bennett, JM
Paietta, E
Longo, W
Gerad, H
Mazza, J
Rowe, JM
Citation: Ms. Gordon et al., Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia - A study of the Eastern Cooperative Oncology Group (ECOG), E5995, LEUK RES, 24(10), 2000, pp. 871-875
Authors:
Robins, HI
Katschinski, DM
Longo, W
Grosen, E
Wilding, G
Gillis, W
Kraemer, C
Tiggelaar, CL
Stewart, JA
Spriggs, D
Arzoomanian, RZ
Feierabend, C
Alberti, D
Morgan, K
Simon, K
d'Oleire, F
Citation: Hi. Robins et al., A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees Cwhole-body hyperthermia, CANC CHEMOT, 43(5), 1999, pp. 409-414
Authors:
Robins, HI
Grosen, E
Katschinski, DM
Longo, W
Tiggelaar, CL
Kutz, M
Winawer, J
Graziano, F
Citation: Hi. Robins et al., Whole body hyperthermia induction of soluble tumor necrosis factor receptors: Implications for rheumatoid diseases, J RHEUMATOL, 26(12), 1999, pp. 2513-2516